Japón - inglés - すりの適正使用協議会 RAD-AR Council, Japan

nippon-chemiphar co.,ltd - silodosin - pale yellowish red tablet, diameter : 8.0 mm, thickness : 3.7 mm

Japón - inglés - すりの適正使用協議会 RAD-AR Council, Japan

nihon generic co.,ltd - silodosin - faint yellowish red tablet with pale yellowish red to yellowish red flecks, diameter: 8.0 mm, thickness: 3.8mm

Japón - inglés - すりの適正使用協議会 RAD-AR Council, Japan

kyorin rimedio co.,ltd. - silodosin - pale yellowish red tablet, diameter 8.0mm, thick 3.9mm

Japón - inglés - すりの適正使用協議会 RAD-AR Council, Japan

kyorin rimedio co.,ltd. - silodosin - white to faintly yellowish white tablet, diameter 6.7mm, thick 3.2mm

Japón - inglés - すりの適正使用協議会 RAD-AR Council, Japan

kyorin rimedio co.,ltd. - silodosin - white to faintly yellowish white tablet, major axis: 11.2mm, minor axis: 6.2mm, thick: 3.6mm

Estados Unidos - inglés - NLM (National Library of Medicine)

avera mckennan hospital - silodosin (unii: cuz39luy82) (silodosin - unii:cuz39luy82) - silodosin 4 mg

Estados Unidos - inglés - NLM (National Library of Medicine)

physicians total care, inc. - silodosin (unii: cuz39luy82) (silodosin - unii:cuz39luy82) - silodosin 8 mg - rapaflo, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph) [see clinical studies (14) ]. rapaflo is not indicated for the treatment of hypertension. - severe renal impairment (ccr < 30 ml/min) severe renal impairment (ccr < 30 ml/min) - severe hepatic impairment (child-pugh score > 10) severe hepatic impairment (child-pugh score > 10) - concomitant administration with strong cytochrome p450 3a4 (cyp3a4) inhibitors (e.g., ketoconazole, clarithromycin, itraconazole, ritonavir) [see drug interactions (7.1) ] concomitant administration with strong cytochrome p450 3a4 (cyp3a4) inhibitors (e.g., ketoconazole, clarithromycin, itraconazole, ritonavir) [see drug interactions (7.1) ] pregnancy category b. rapaflo is not indicated for use in women. an embryo/fetal study in rabbits showed decreased maternal body weight at 200 mg/kg/day (approximately 13-25 times the maximum recommended human exposure or mrhe of silod

Kenia - inglés - Pharmacy and Poisons Board

innocia lifesciences private ltd 12, balaji nagar, ambattur, chennai - 53, - silodosin capsules 4mg - capsule - silodosin capsules 4mg - silodosin

Kenia - inglés - Pharmacy and Poisons Board

m/s. innocia lifesciences pvt. ltd. 12, balaji nagar, ambattur, chennai – 53, - silodosin capsules 8mg - capsule - silodosin capsules 8mg - silodosin

Kenia - inglés - Pharmacy and Poisons Board

silodosin 4mg and dutasteride 0.5mg - capsule - silodosin 4mg and dutasteride 0.5mg - silodosin